Hong L, Miyamoto S, Hashimoto N, Tabata Y
Institute for Frontier Medical Sciences, Graduate School of Medicine, Kyoto University, Japan.
J Biomater Sci Polym Ed. 2000;11(12):1357-69. doi: 10.1163/156856200744381.
The objective of this study is to examine whether or not bone formation at a skull bone defect induced by gelatin microspheres incorporating transforming growth factor (TGF)-beta1 is promoted by prevention of fibrous tissues into the defect. The 6-mm diameter bone defect of rabbit skulls was applied with gelatin microspheres incorporating TGF-beta1 or free TGF-beta1 and physically covered by a barrier membrane. When the bone formation at the defect was assessed 6 weeks postoperatively, combinational application of gelatin microspheres incorporating 0.1 microg of TGF-beta1 with the barrier membrane induced bone formation at the skull defect, in marked contrast to that of 0.1 microg of free TGF-beta1 and empty gelatin microspheres. Complete defect closure was histologically observed by the newly formed bone tissue. Without the barrier membrane, gelatin microspheres incorporating TGF-beta1 were less effective in inducing bone formation, whereas free TGF-beta1 and empty gelatin microspheres were ineffective. The skull defect was occupied by fibrous tissue infiltrated in place of bone tissue. The bone mineral density at the skull defect applied with gelatin microspheres incorporating TGF-beta1 plus the membrane was significantly higher than that of gelatin microspheres incorporating TGF-beta1 alone. The present data indicated that physical protection from the soft tissue infiltration enabled gelatin microspheres incorporating TGF-beta1 to synergistically enhance the osteoinductive ability at the skull defect.
本研究的目的是检验通过防止纤维组织长入颅骨缺损处,含转化生长因子(TGF)-β1的明胶微球是否能促进颅骨缺损处的骨形成。对兔颅骨直径6毫米的骨缺损处应用含TGF-β1的明胶微球或游离TGF-β1,并通过屏障膜进行物理覆盖。术后6周评估缺损处的骨形成情况时,含0.1微克TGF-β1的明胶微球与屏障膜联合应用可诱导颅骨缺损处的骨形成,这与0.1微克游离TGF-β1和空明胶微球形成显著对比。组织学观察发现,新形成的骨组织实现了缺损的完全闭合。没有屏障膜时,含TGF-β1的明胶微球诱导骨形成的效果较差,而游离TGF-β1和空明胶微球则无效。颅骨缺损处被浸润的纤维组织占据,取代了骨组织。应用含TGF-β1的明胶微球加屏障膜的颅骨缺损处的骨矿物质密度显著高于单独应用含TGF-β1的明胶微球。目前的数据表明,对软组织浸润的物理防护能使含TGF-β1的明胶微球协同增强颅骨缺损处的骨诱导能力。